Close Menu

    Get the latest news around the globe

    Editor's Pick

    Straight men carrying ‘bisexual genes’ tend to have more children

    Ancient viruses help in fighting cancer; Study

    Meta unveils new AI products at developer conference

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) LinkedIn Instagram
    Britain HeraldBritain Herald
    Subscribe
    • Home
    • World Roundup
    • Business
    • Tech World
    • Entertainment & Events
    • Curious
    • More…
      • Spotlight
      • Knowledge
      • Lifestyle
      • Awareness
      • Women World
      • Sports
      • Travel
      • Notable
      • Contact Us
    Britain HeraldBritain Herald
    Home » US approves world’s 1st chikungunya vaccine
    World Roundup

    US approves world’s 1st chikungunya vaccine

    The US FDA's approval of Ixchiq is expected to speed up the vaccine's implementation in countries where the virus is most prevalent.
    Editorial DeskBy Editorial DeskNovember 10, 2023
    Facebook Twitter LinkedIn WhatsApp
    AstraZeneca pulls COVID-19 vaccine worldwide
    Rep. Image: Artem Podrez @ Pexels

    Washington: The US Food and Drug Administration (FDA) has approved the world’s first vaccine for chikungunya, a virus spread by infected mosquitoes.

    According to the FDA, the vaccine, developed by Europe’s Valneva which will be marketed under the name Ixchiq, has been licensed for people 18 and over who are at increased risk of exposure.

    The US FDA’s approval of Ixchiq is expected to speed up the vaccine’s implementation in countries where the virus is most prevalent.

    US FDA
    Image: Wikipedia

    Chikungunya, which causes fever and severe joint pain, is most commonly encountered in Africa, Southeast Asia, and part of the Americas.

    “However, chikungunya virus has spread to new geographical areas causing a rise in global prevalence of the disease,” the FDA said, reporting more than five million cases in the past 15 years.

    In a statement, Mr. Peter Marks Senior Official of the FDA, remarked that, “Infection with chikungunya virus can lead to severe disease and prolonged health problems, particularly for older adults and individuals with underlying medical conditions.”

    chikungunyaa
    Rep. Image: Wikimedia Commons

    “Today’s approval addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options,” Mr. Marks added.

    The vaccine is administered in a single dose and contains a live, weakened version of the chikungunya virus. In North America, two clinical studies involving 3,500 participants were conducted.  Headache, fatigue, muscle and joint pain, fever, and nausea were commonly reported side effects.

    In the trials, 1.6 percent of Ixchiq recipients experienced serious responses, with two requiring hospitalization.

    TRENDING | Blood tests can detect Crohn’s disease much earlier; Study

    STAR OF SECTOR 2025
    chikungunya chikungunya Vaccine FDA US Food and Drug Administration Vaccine Valneva
    Share. Facebook Twitter LinkedIn WhatsApp
    Editorial Desk
    Editorial Desk

    The article published above represents the viewpoint or opinion of the Chief Editor of Britain Herald. It does not reflect the general opinion of the Britain Herald management or its writers. If you have any inquiries or complaints about the published material, please contact us at BritainHerald@Gmail.Com

    Newly Updated

    UK to announce fresh sanctions on shadow fleet

    May 9, 2025

    US-China trade talks: Trump signals tariff reduction

    May 9, 2025

    London Mayor Sadiq Khan backs green belt development

    May 9, 2025
    STAR OF SECTOR 2025

    Business

    US-China trade talks: Trump signals tariff reduction

    World Roundup May 9, 2025

    United States: US President Donald Trump has hinted at a potential easing of tariffs on…

    MJ Mathew Takes Executive Role at WellMade Network

    May 8, 2025

    UK and India sign trade deal to slash tariffs and boost exports

    May 7, 2025

    DoorDash to take over Deliveroo in landmark international deal

    May 6, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • LinkedIn
    • Instagram

    Curious

    Glowing Spiral appears in night sky; Linked to SpaceX Falcon 9 Rocket

    March 25, 2025

    Once dubbed ‘Ugliest’; Blobfish triumphs as NZ ‘Fish of the Year’

    March 19, 2025

    Giant Iceberg A23a runs aground near South Georgia; Easing wildlife fears

    March 5, 2025

    NASA Astronauts to return after nine months in Space

    March 5, 2025

    Get the latest news around the globe

    Knowledge

    Kashmir conflict: History of disputes, wars, and unresolved tensions

    World Roundup May 9, 2025

    New Delhi, India / Islamabad, Pakistan: The Kashmir conflict between India and Pakistan has spanned…

    Snakebite survivor’s blood sparks universal antivenom discovery

    May 3, 2025

    ESA’s Biomass satellite set for launch to map forest carbon

    April 29, 2025

    Gigil: The new dictionary word for irresistible cuteness overload

    March 27, 2025
    18-EA-387-TryEngineeringSummerInst_BannerAd_300x250_Robot
    About Us
    About Us

    Britain Herald is a global news brand that plays a significant role in educating and informing the masses with informative content, the latest updates, and current affairs across the World.

    Operated and Managed by WellMade Network, the portal is a sister concern of GCC Business News and Emirati Times. For inquiries about Media Partnerships, Investment and other opportunities in line with our Editorial Policy, please contact us at;

    Email Us: News@BritainHerald.com
    Whatsapp: +971 5060 12456

    We Have

    UK to announce fresh sanctions on shadow fleet

    May 9, 2025

    US-China trade talks: Trump signals tariff reduction

    May 9, 2025

    London Mayor Sadiq Khan backs green belt development

    May 9, 2025

    Kashmir conflict: History of disputes, wars, and unresolved tensions

    May 9, 2025
    Facebook X (Twitter) LinkedIn Instagram
    • Home
    • Business
    • Tech World
    • Awareness
    • Contact Us
    Privacy & Cookies Policy | Terms & Conditions
    © 2002 BritainHerald.com, An Initiative by WellMade Network

    Type above and press Enter to search. Press Esc to cancel.